Romain Bertrand

Title: Romain Bertrand: Innovator in Antibody-Drug Conjugates

Introduction

Romain Bertrand is a notable inventor based in Au, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work focuses on enhancing the efficacy of therapeutic agents through advanced conjugation techniques.

Latest Patents

Romain Bertrand holds a patent for "Antibody-drug conjugates through specific linker oligopeptides." This invention relates to a method for generating an antibody-payload conjugate using microbial transglutaminase (MTG). The method involves conjugating a linker to a Gln residue in an antibody, utilizing a specific structure that includes various chemical spacers and linking moieties. This innovative approach aims to improve the delivery and effectiveness of therapeutic antibodies.

Career Highlights

Throughout his career, Romain Bertrand has been associated with Araris Biotech AG, a company dedicated to advancing biopharmaceuticals. His work has been instrumental in developing novel therapeutic strategies that leverage the power of antibody-drug conjugates. With a focus on precision and efficacy, he continues to push the boundaries of what is possible in the field of biotechnology.

Collaborations

Romain Bertrand collaborates with talented professionals in his field, including Philipp Spycher and Philipp Probst. These collaborations enhance the innovative potential of his work and contribute to the advancement of biotechnological solutions.

Conclusion

Romain Bertrand's contributions to the field of antibody-drug conjugates exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Araris Biotech AG highlight the importance of collaboration and creativity in developing effective therapeutic solutions.